Fresenius Medical Care AG & Co. is a German company that provides products and services for people with chronic kidney failure, also known as end-stage renal disease. The company operates in more than 120 countries worldwide, with more than 4,000 clinics providing dialysis treatment to over 345,000 patients. The company was founded in 1996 through the merger of two companies, Fresenius AG and American company National Medical Care.
Fresenius Medical Care operates in two business segments: dialysis services and dialysis products. The dialysis services segment provides services to patients with chronic kidney disease, including hemodialysis, peritoneal dialysis, and home dialysis. The dialysis products segment manufactures and distributes dialysis products such as hemodialysis machines, peritoneal dialysis solutions, and other related products.
Fresenius Medical Care went public in 1996 and is listed on the Frankfurt Stock Exchange and the New York Stock Exchange. The company has grown significantly since its founding, with acquisitions such as the purchase of Renal Care Group in 2006 and Liberty Dialysis in 2012. In addition to its core business, the company has also expanded into related fields, such as pharmacy services, remote monitoring of patients, and telemedicine.
Fresenius Medical Care has been recognized for its commitment to quality patient care and has received numerous awards and accolades for its work. The company has also been recognized for its commitment to sustainability and has been included in various sustainability indices, such as the Dow Jones Sustainability Indices.